Prestige Consumer Healthcare Inc. (PBH) Company Bio
Prestige Brands Holdings markets and distributes brand name over-the-counter health-care and household products throughout the U.S., Canada, Australia, and in certain other international markets. Core brands include Monistat women's health products, Nix lice treatments, Chloraseptic sore throat treatments, Compound W wart treatments, Clear Eyes eye care products, Little Remedies pediatric products, The Doctor's NightGuard dental protector, Efferdent denture care products, Luden's throat drops, Dramamine motion sickness treatments, BC and Goody's headache remedies, Beano gas prevention, Debrox earwax remover, and in Canada, Gaviscon antacid. The company was founded in 1996 and is based in Tarrytown, New York.
PBH Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for PBH, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Prestige Consumer Healthcare Inc ranked in the 58th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 34.83% on a DCF basis. The most interesting components of our discounted cash flow analysis for Prestige Consumer Healthcare Inc ended up being:
55% of the company's capital comes from equity, which is greater than just 23.89% of stocks in our cash flow based forecasting set.
Prestige Consumer Healthcare Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 8.13% of tickers in our DCF set.
Relative to other stocks in its sector (Healthcare), Prestige Consumer Healthcare Inc has a reliance on debt greater than 86.74% of them.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Prestige Consumer Healthcare Inc? See HBIO, JAZZ, HRC, UTHR, and CHE.
TARRYTOWN, N.Y., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 third quarter earnings release on Thursday, February 4, 2021 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate via phone listeners calling from the U.S. and Canada may dial 844-233-9440, or 574-990-1016 internationally, using the conference ID 4948099. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com.Telephonic replays will be available for approximately one week following completion of the live call and can be accessed at 8...
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]